The Endpoint Determines What the Trial Actually Proved
A missed primary endpoint doesn't always read as a miss. Check whether an AI trial summary attributed its headline claim to the right endpoint.
Who this is for
Healthcare and life sciences researchers — Medical writers and researchers checking whether an AI summary correctly attributed a trial's result to the right endpoint type
The problem
A trial can hit its secondary endpoint, miss its primary endpoint, and still get summarized as "the drug worked" if the summary doesn't distinguish which endpoint actually produced the positive result. A surrogate endpoint — a biomarker change, say — getting reported with the same weight as an actual clinical outcome is a related and equally common compression.
The endpoint is what the trial was designed and powered to test. Reporting the result without naming the endpoint type strips out the single piece of context that determines how much the result should actually change anyone's confidence.
How ConvergePanel helps
ConvergePanel checks an AI-generated trial summary against the endpoint structure across five models: was the reported result on the primary endpoint or a secondary one, was it prespecified or found post hoc, and does a surrogate endpoint get presented with the certainty of a hard clinical outcome. Where models disagree on which endpoint a claim is actually based on, that's the detail to trace back to the trial's own methods section.
How they compare
| Endpoint | Type | Result | AI Interpretation | Reviewer Conclusion |
|---|---|---|---|---|
| Overall survival | Primary, prespecified | Not statistically significant | Summary emphasizes a different result as the headline finding | State plainly that the primary endpoint did not reach significance |
| Biomarker reduction | Secondary, surrogate endpoint | Statistically significant improvement | Summary presents this as evidence the treatment 'worked' for patients | Note this is a surrogate marker, not a demonstrated clinical outcome, until outcome data confirms it |
| Subgroup response in one age band | Post hoc, not prespecified | Statistically significant within the subgroup | Summary cites this as a key finding without noting it wasn't prespecified | Flag as exploratory and hypothesis-generating, not confirmatory |
How it works
- 1Identify the trial's prespecified primary endpoint from its registration or methods section
- 2Check whether the AI summary's headline claim is based on the primary endpoint or a secondary one
- 3Check whether a surrogate endpoint is being presented as equivalent to a clinical outcome
- 4Confirm whether a cited subgroup or secondary finding was prespecified or identified post hoc
- 5Assess statistical significance separately from clinical relevance for each endpoint cited
- 6Flag any summary that elevates a secondary or post hoc finding to the trial's main conclusion
Use cases
- Checking whether a positive result comes from the primary endpoint or a secondary one
- Verifying a surrogate endpoint isn't presented as a clinical outcome
- Confirming a cited subgroup finding was prespecified, not identified after the fact
- Auditing an AI-generated trial summary before it's cited in a report
Ten endpoint distinctions that change what a result means
- Primary endpoint — the trial's pre-specified main measure of success
- Secondary endpoint — supporting measures, evidentiary weight is lower
- Exploratory endpoint — hypothesis-generating, not designed to confirm anything
- Surrogate endpoint — a marker (like a biomarker) standing in for a real clinical outcome
- Composite endpoint — several outcomes combined into one measure, which can mask which component drove the result
- Safety endpoint — measures harm, not efficacy, and deserves separate attention
- Statistical significance — the result is unlikely to be due to chance
- Clinical significance — the effect size is large enough to matter to a patient
- Prespecified analysis — planned before the data was examined
- Post hoc analysis — identified after looking at the data, and evidentiarily weaker as a result
Why a missed primary endpoint doesn't read as a miss
When a trial misses its primary endpoint but shows a positive secondary or post hoc result, the natural next step in a write-up is to lead with the positive finding — which is exactly how a missed primary endpoint stops reading as a miss. Nothing about the sentence is false; the reporting order alone determines the impression.
The check here isn't complicated: find the primary endpoint, find its actual result, and confirm the summary states that result plainly before anything else gets emphasized.
Frequently asked questions
Does a positive secondary endpoint still count as evidence?
Yes, but with less weight than a primary endpoint result — trials are statistically powered around their primary endpoint, and secondary findings are more prone to chance and should be treated as supportive, not conclusive.
Why does it matter if an endpoint is a surrogate marker?
Because a surrogate marker moving in the right direction doesn't guarantee the actual clinical outcome it's meant to predict will follow — surrogate-to-outcome relationships sometimes fail to hold, which is exactly why regulators often require outcome data before treating a surrogate result as sufficient.
Is a post hoc subgroup finding worthless?
No — it's hypothesis-generating and can justify a follow-up trial. It's the wrong basis for a confirmed conclusion, which is the distinction that matters when a summary treats it as one.
How do I find a trial's actual prespecified primary endpoint?
Trial registries (where the study was registered before enrollment began) list the prespecified primary endpoint — checking the registration against the published summary is the most reliable way to catch a post hoc endpoint being presented as primary.
Can ConvergePanel determine whether an endpoint result is clinically meaningful?
No. It compares model interpretations of endpoint type and prespecification status — determining clinical meaningfulness requires a qualified clinician or biostatistician evaluating the actual effect size and patient context.
Explore related pages
ConvergePanel provides AI-assisted verification for informational purposes only. Not forensic analysis. Not legal evidence.
More in How-To
How to Verify a Viral Claim with AI
How does AI claim verification actually work? Learn the mechanics: independent model queries, consensus scoring, and how to read disagreement as a research signal.
How to Review a Suspicious Video with AI
Use AI-assisted review to check suspicious videos for context, visual claims, manipulation risk, and source uncertainty.
How to Verify a Viral Claim Before You Share It
Viral claims travel six times faster than corrections. Check the source, date, and model disagreement in under two minutes before you share.